ACSO GI - Gastric Cancer Survival

<body topmargin=0 leftmargin=0 marginheight=0 marginwidth=0> <table cellpadding=0 cellspacing=0 border=0 height="100%"><tr> <td valign="top" width=200 BGCOLOR="#3300CC" TEXT="#080000"> <bR> <bR> <div> <A HREF="home.htm" TARGET="_top" TITLE="DSTW Homepage"><U><IMG SRC="11b5e1b0.gif" border=0 width="94" height="27" ALIGN="BOTTOM" HSPACE="0" VSPACE="0"></U></A></div> <div> <B><table border='0' cellspacing='2' cellpadding='2'><tr><td align="center"></td><td align='center'><a href='http://server.iad.liveperson.net/hc/53149936/?cmd=file&file=visitorWantsToChat&site=53149936&byhref=1' target='chat53149936' onClick="javascript:window.open('http://server.iad.liveperson.net/hc/53149936/?cmd=file&file=visitorWantsToChat&site=53149936&referrer='+escape(document.location),'chat53149936','width=472,height=320');return false;" ><img src='http://server.iad.liveperson.net/hc/53149936/?cmd=repstate&site=53149936&&ver=1&category=en;woman;4' name='hcIcon' width=160 height=65 border=0></a></td></tr><tr><td> </td><td align='center'><a href='http://www.liveperson.com' style='text-decoration:none'><font face='Arial' size='-2' color='#333333'><span style='font-size: 10px; font-family: Arial, Helvetica, sans-serif'>Live chat by<font color='#475780'> Live</font><font color='#56A145'>Person</font></span></font></a></td></tr></table></B></div> <div> <B><script language='javascript' src='http://server.iad.liveperson.net/hc/53149936/x.js?cmd=file&file=chatScript3&site=53149936&&category=en;woman;4'> </script></B></div> <bR> </td> <td valign="top" BGCOLOR="#FFFFFF" TEXT="#080000"> <div> <FONT SIZE="5" COLOR="#0066FF" FACE="Short Hand" ><B>Don't Say That Word</B></FONT><FONT SIZE="1" COLOR="#333399" FACE="Short Hand" >   </FONT><FONT SIZE="1" COLOR="#333399" FACE="Arial" > </FONT><FONT SIZE="1" COLOR="#000000" FACE="Arial" > | </FONT><FONT SIZE="2" COLOR="#000000" FACE="Arial" > </FONT><B>   </B><A HREF="index.htm" TARGET="_top" TITLE="Dont Say That Word"><U><B>home</B></U></A><B>            </B><FONT SIZE="1" COLOR="#000000" FACE="Arial" >                                                                           </FONT><FONT SIZE="2" COLOR="#000000" FACE="Arial" ><IMG SRC="10f4cb3a0.png" border=0 width="203" height="58" ALIGN="BOTTOM" HSPACE="0" VSPACE="0"></FONT></div> <div> <A HREF="id104.htm" TARGET="_top" TITLE="Asprin may prevent prostate cancer"><U>Asprin may prevent prostate cancer</U></A>   |   <A HREF="id102.htm" TARGET="_top" TITLE="All Drugs Need Not Be Smart Bombs"><U>All Drugs Need Not Be Smart Bombs</U></A>   |   <A HREF="id103.htm" TARGET="_top" TITLE="New Cancer Drug..."><U>New Cancer Drug...</U></A>   |   <A HREF="id55.htm" TARGET="_top" TITLE="Hair Dye May Raise Cancer Risk"><U>Hair Dye May Raise Cancer Risk</U></A>   |   <A HREF="id74.htm" TARGET="_top" TITLE="Treatment Plea"><U>Treatment Plea</U></A>   |   <A HREF="id73.htm" TARGET="_top" TITLE="NonSurgical Treatment"><U>Non-Surgical Treatment</U></A>   |   <A HREF="id72.htm" TARGET="_top" TITLE="HighTech Tool Breakthrough Cancer"><U>High-Tech Tool - Breakthrough Cancer</U></A>   |   <A HREF="id71.htm" TARGET="_top" TITLE="Deodorants"><U>Deodorants</U></A>   |   <A HREF="id70.htm" TARGET="_top" TITLE="Hair dye may raise cancer risk"><U>Hair dye may raise cancer risk</U></A>   |   <A HREF="id69.htm" TARGET="_top" TITLE="Corporate Jamaica helps"><U>Corporate Jamaica helps</U></A>   |   <A HREF="id68.htm" TARGET="_top" TITLE="Study Links Some Hair Dyes to Kind of Ca"><U>Study Links Some Hair Dyes to Kind of Cancer</U></A>   |   <A HREF="id67.htm" TARGET="_top" TITLE="ASCO GI Clear Survival Benefits Not Evi"><U>ASCO GI - Clear Survival Benefits Not Evident</U></A>   |   <A HREF="id66.htm" TARGET="_top" TITLE="ASCO GI Imatinib Give Sustained Respons"><U>ASCO GI - Imatinib Give Sustained Response</U></A>   |   <B>ACSO GI - Gastric Cancer Survival </B>   |   <A HREF="id64.htm" TARGET="_top" TITLE="ASCO GI Chemoradiation Benefit Holds Up"><U>ASCO GI - Chemoradiation Benefit Holds Up..</U></A>   |   <A HREF="id63.htm" TARGET="_top" TITLE="Cancer Patients Wait So Targets Are Met"><U>Cancer Patients Wait So Targets Are Met</U></A>   |   <A HREF="id62.htm" TARGET="_top" TITLE="Cancer Gene Double Whammy"><U>Cancer Gene - "Double Whammy"</U></A>   |   <A HREF="id61.htm" TARGET="_top" TITLE="Hair Dye May Raise Cancer Risk: Study"><U>Hair Dye May Raise Cancer Risk: Study</U></A>   |   <A HREF="id60.htm" TARGET="_top" TITLE="New Cancer Drugs To Watch"><U>New Cancer Drugs To Watch</U></A>   |   <A HREF="id57.htm" TARGET="_top" TITLE="Breakthrough In Cancer Research By Babra"><U>Breakthrough In Cancer Research By Babraham</U></A>   |   <A HREF="index.htm" TARGET="_top" TITLE="Dont Say That Word"><U>Don't Say That Word</U></A></div> <div> ACSO GI - Gastric Cancer Survival </div> <div> .....Linked to Number of Nodes Dissected</div> <bR> <div> Prognosis in patients who survive gastric cancer is linked to the number of lymph nodes that are dissected, according to results of a database analysis presented here January 22<FONT SIZE="1" COLOR="#000000" FACE="Arial" >nd</FONT> at the First Annual Symposium on Gastrointestinal Cancer, sponsored jointly by the American Society of Clinical Oncology and other societies.</div> <bR> <div> Roderich Schwarz, MD, of the Cancer Institute of New Jersey, New Brunswick, New Jersey, presented findings of an analysis of data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program, a source of information on cancer incidence and survival in the United States.</div> <bR> <div> The number of nodes examined significantly predicts survival after resection of gastric cancer, Dr. Schwarz said. For fewer than 10 nodes dissected, compared to more than ten, the <I>P</I> value was .0002 for the difference in 5 year survival rates. A 7.6% increase in 5 year survival appeared for each additional node examined in one subgroup, he said, and by 5% to 11% in the others studied.</div> <bR> <div> Of 3 million patients in the SEER database who were entered between 1973 and 1999, investigators identified a cohort of 15,738 patients. Of these, 5,109 had gastric adenocarcinoma with at least one node examined, and enough information to allow analysis. Most had fewer than 10 nodes dissected. Only 20% of patients met the current recommendations for 50 nodes to be examined.</div> <bR> <div> Staging of gastric cancer culled from the database was by American Joint Committee on Cancer (AJCC) TNM criteria, which is based on the extent of the tumor (T), spread to lymph nodes (N), and metastasis (M).</div> <bR> <div> Stages among patients in the SEER database were T1/2NO, T1/2N1, T3N0, and T3N1. All stages showed better overall survival with increasing number of nodes examined, Dr. Schwarz said.</div> <bR> <div> "The bottom line is, each subgroup analyzed had an improvement, stepwise, in survival, that persisted to more than 40 nodes [removed]," he explained.</div> <bR> <div> "It should be mandatory to look at  least 10 nodes," he added, "and the more nodes you get, the better. Ask your pathologist to find as many lymph nodes as possible."</div> <bR> <div> "Extended lymph node may impact on strategy choices" for treating the cancer, said Dr. Schwarz. Yet the number of nodes removed may serve as "a surrogate for a different pattern of care," Dr. Schwarz said in response to comment from the audience.</div> <div> <I> <embed src="HTMLobj-197/angel.mid" autostart="true" loop="true" hidden="true">  </I></div> </td> </tr></table></body>